Skip to main content
. 2017 Feb 27;12:41. doi: 10.1186/s13014-017-0781-4

Fig. 4.

Fig. 4

Marker at MOSkin location on CBCT scan taken following a patient treatment. The CTV and 50% isodose regions appear in purple